Abstract:BackgroundCardiac Implantable Electronic Devices (CIEDs) are widely used for the management of advanced heart failure and ventricular arrhythmias. CIED‐Infection (CIED‐I) has very high mortality, especially in the subsets of patients with limited health‐care access and delayed presentation. The purpose of this study is to identify the risk‐predictors mortality in subjects with CIED‐I.MethodsWe performed a retrospective cohort study of a regional database in patients presenting with CIED infections to tertiary care medical centers across Western New York, USA from 2012 – 2020. The clinical outcomes included recurrent device infection (any admission for CIED‐I after the first hospitalization for device infection), septic complications (pulmonary embolism, respiratory failure, septic shock, decompensated HF, acute kidney injury) and mortality outcomes (death during hospitalization, within 30 days from CIED‐I, and within 1 year from CIED‐I). We studied associations between categorical variables and hard outcomes using chi‐square tests and used one‐way analysis of variance to measure between‐groups differences.ResultsWe identified 296 patients with CIED‐I, among which 218 (74%) were male, 237 (80%) were white and the mean age at the time of infection was 69.2±13.7 years. One‐third of the patients were referred from the regional facilities. Staphylococcus aureus was responsible for most infections, followed by Enterococcus fecalis. On multivariate analysis, the covariates associated with significantly increased mortality risk included referral from regional facility (OR: 2.0;1.0‐4.0), hypertension (Odds ratio, OR: 3.2;1.3‐8.8), right ventricular dysfunction (OR: 2.6;1.2‐5.1), end‐stage renal disease (OR: 2.6;1.1‐6.2), immunosuppression (OR: 11.4;2.5‐53.3), and septic shock as a complication of CIED‐I (OR: 3.9;1.3‐10.8).ConclusionHypertension, right ventricular dysfunction, immunosuppression, and end‐stage renal disease are associated with higher mortality after CIED‐I. Disproportionately higher mortality was also noted in subjects referred from the regional facilities. This underscores the importance of early clinical risk‐assessment, and the need for a robust referral infrastructure to improve patient outcomes.This article is protected by copyright. All rights reserved.

Device infection in patients undergoing pacemaker or defibrillator surgery: risk stratification using the PADIT score

Burden of disease and costs of infections associated with cardiac implantable electronic devices

Measures to Prevent Infection in Cardiac Implantable Electronic Device Replacements or Upgrades

The Blister Score: A Novel, Externally Validated Tool for Predicting Cardiac Implantable Electronic Device Infections, and Its Cost-utility Implications for Antimicrobial Envelope Use

Prevention and Risk Assessment of Cardiac Device Infections in Clinical Practice

Infection in patients with subcutaneous implantable cardioverter-defibrillator: Results of the S-ICD Post Approval Study

Prevention and Management of Cardiac Implantable Electronic Device Infections: State-of-the-Art and Future Directions

Incidence and Predictors of Infections and All-Cause Death in Patients with Cardiac Implantable Electronic Devices: The Italian Nationwide RI-AIAC Registry

Risk Factors Associated with Higher Mortality in Patients with Cardiac Implantable Electronic Device Infection

Tailored Care for Cardiac Health: Risk Stratification and Gentamicin-Infused Collagen Sponges to Minimize Cardiac Device Infections and Healthcare Costs

Antibiotic eluting envelopes: evidence, technology, and defining high-risk populations

Factors associated with cardiac implantable electronic device‐related infections, New South Wales, 2016–21: a retrospective cohort study

Risk of Cardiovascular Implantable Electronic Device Infection in Patients Presenting With Gram-Negative Bacteremia

Cardiac surgery in patients with cardiac implantable electronic devices and risk of device infections: a nationwide nested case–control study

Randomized Trial of Stand-Alone Use of the Antimicrobial Envelope in High-Risk Cardiac Device Patients

Economic evaluation of an absorbable antibiotic envelope for prevention of cardiac implantable electronic device infection

Abstract 15148: Contemporary Trends of Antibacterial Envelope Use to Prevent Cardiac Implantable Device Infection: Insights From the National Readmission Database

Cardiovascular implantable electronic device infections due to enterococcal species: Clinical features, management, and outcomes

Infective Endocarditis Involving Implanted Cardiac Electronic Devices: JACC Focus Seminar 1/4

The role of an antibiotic envelope in the prevention of major cardiac implantable electronic device infections: A systematic review and meta-analysis

Antibiotic-Eluting Envelopes to Prevent Cardiac-Implantable Electronic Device Infection: Past, Present, and Future